NeuroRx Pharma Revenue and Competitors
Estimated Revenue & Valuation
- NeuroRx Pharma's estimated annual revenue is currently $3.1M per year.
- NeuroRx Pharma's estimated revenue per employee is $155,000
Employee Data
- NeuroRx Pharma has 20 Employees.
- NeuroRx Pharma grew their employee count by -26% last year.
NeuroRx Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Founder, Chairman, and CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Director Medical Writing | Reveal Email/Phone |
5 | Associate Director Clinical Operations and Medical | Reveal Email/Phone |
6 | Chief Technology Officer | Reveal Email/Phone |
7 | Chief Business Officer | Reveal Email/Phone |
8 | Medical Director | Reveal Email/Phone |
9 | Regulatory Affairs Officer | Reveal Email/Phone |
10 | Clinical Program Manager | Reveal Email/Phone |
NeuroRx Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is NeuroRx Pharma?
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NeuroRx Pharma News
2022-04-19 - US Psychedelic Drugs Market Is Expected To Reach USD ...
Avadel (Ireland), Celon Pharma S.A. (Poland), Johnson & Johnson Private ... (US), NeuroRx, Inc. (US), Jazz Pharmaceuticals, Inc. (Ireland),...
2022-04-19 - Relief Therapeutics' Wholly Owned Subsidiary, APR Applied ...
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, ... NeuroRx, Inc. Relief also has a Collaboration and License...
2022-04-17 - Relief Reports that its U.S. Collaboration Partner has Filed a New
Breakthrough Therapy Designation Request for Aviptadil
... NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx"), of its collaboration partner with respect to aviptadil, NeuroRx, Inc. ("NeuroRx"),.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.3M | 20 | -13% | N/A |
#2 | $2M | 20 | -5% | N/A |
#3 | $2M | 20 | N/A | N/A |
#4 | $2M | 20 | N/A | N/A |
#5 | $2M | 20 | N/A | N/A |
